KYMR Kymera Therapeutics, Inc.

Fundamentals / CIK 0001815442 / USD

Kymera Therapeutics, Inc. reported $102.2M in revenue and a net loss of $349.4M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a 0.0% gross margin and a -396.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KYMR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$110.3M$55.17M$0-$297.8MFY 2019 Revenue: $2.93MFY 2019 Net Income: -$41.25M2019FY 2020 Revenue: $34.03MFY 2020 Net Income: -$45.59M2020FY 2021 Revenue: $72.83MFY 2021 Net Income: -$100.2M2021FY 2022 Revenue: $46.83MFY 2022 Net Income: -$154.8M2022FY 2023 Revenue: $78.59MFY 2023 Net Income: -$147.0M2023FY 2024 Revenue: $47.07MFY 2024 Net Income: -$223.9M2024FY 2025 Revenue: $39.21MFY 2025 Net Income: -$311.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $39.21M $47.07M $78.59M $46.83M $72.83M $34.03M $2.93M
Cost of Revenue $39.21M $47.07M $78.59M $46.83M -- -- --
Gross Profit $0 $0 $0 $0 -- -- --
Research & Development $316.6M $240.2M $189.1M $164.2M $137.0M $62.10M $37.16M
Total Operating Expenses $388.6M $308.7M $244.1M $208.1M $173.4M $80.34M $45.14M
Operating Income -$349.4M -$261.6M -$165.5M -$161.3M -$100.5M -$46.30M -$42.20M
EBITDA -$341.1M -$254.3M -$162.0M -$158.3M -$98.13M -$44.54M -$41.38M
Interest Income $38.42M $38.03M $18.76M $6.62M -- -- --
Income Before Tax -$311.4M -- -- -- -- -- --
Income Tax Expense $0 -- -- $0 $0 $0 $0
Net Income -$311.4M -$223.9M -$147.0M -$154.8M -$100.2M -$45.59M -$41.25M
Basic EPS -$3.69 -$2.98 -$2.52 -$2.87 -$2.09 -$3.15 -$24.28
Diluted EPS -$3.69 -$2.98 -$2.52 -$2.87 -$2.09 -$3.15 -$24.28
Basic Shares Outstanding 84.5M 75.0M 58.4M 53.9M 48.0M 17.3M 1.7M
Diluted Shares Outstanding 84.5M 75.0M 58.4M 53.9M 48.0M 17.3M 1.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $65.00M $34.37M $2.87M $2.76M $11.48M $22.10M $7.39M
Cost of Revenue $0 $65.00M $34.37M $2.87M $2.76M $11.48M $22.10M $7.39M
Gross Profit $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $128.5M $119.5M $98.16M $83.83M $74.09M $78.39M $80.25M $71.82M
Total Operating Expenses $147.2M $140.6M $118.5M $100.8M $95.28M $96.03M $96.53M $88.15M
Operating Income -$147.2M -$75.61M -$84.15M -$97.90M -$92.52M -$84.56M -$74.43M -$80.75M
EBITDA -$145.2M -$73.58M -$82.13M -$95.86M -$90.37M -$82.47M -$72.38M -$78.77M
Interest Income $15.29M $14.48M $14.98M $11.01M $10.44M $8.05M $8.92M $10.06M
Net Income -$132.0M -$61.21M -$69.23M -$86.98M -$82.17M -$76.61M -$65.58M -$70.75M
Basic EPS -$1.32 -$0.62 -$0.71 -- -$0.94 -$0.95 -$0.82 --
Diluted EPS -$1.32 -$0.62 -$0.71 -- -$0.94 -$0.95 -$0.82 --
Basic Shares Outstanding 100.1M 98.2M 97.5M -- 87.3M 80.4M 80.1M --
Diluted Shares Outstanding 100.1M 98.2M 97.5M -- 87.3M 80.4M 80.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $357.0M $120.3M $110.0M $68.39M $47.98M $31.00M $76.02M
Short-Term Investments $491.3M $368.5M $264.9M $338.8M $394.4M $265.2M $15.94M
Cash & Short-Term Investments $848.3M $488.7M $374.9M $407.2M $442.4M $296.2M $91.96M
Accounts Receivable, Net $0 $0 $15.00M $0 -- -- --
Total Current Assets $871.2M $510.3M $405.3M $419.4M $451.3M $302.3M $92.84M
Property, Plant & Equipment, Net $43.17M $50.46M $48.13M $13.33M $11.88M $10.84M $3.79M
Long-Term Investments $771.2M $362.2M $61.43M $152.3M $125.2M $162.5M --
Other Non-Current Assets $9.11M $1.95M $2.12M $3.02M $2.02M $30K $1.77M
Total Non-Current Assets $871.6M $467.8M $170.4M $183.7M $154.6M $184.8M $23.86M
Total Assets $1.74B $978.0M $575.8M $603.1M $605.9M $487.2M $116.7M
Accounts Payable $4.01M $5.99M $7.08M $4.33M $4.00M $4.37M $3.28M
Deferred Revenue (Current) $22.93M $13.58M $37.88M $35.26M $61.74M $92.55M $23.35M
Other Current Liabilities $242K $223K $524K $303K $228K $106K --
Total Current Liabilities $83.21M $67.77M $85.69M $71.34M $92.54M $110.6M $34.57M
Deferred Revenue (Non-Current) $11.44M $0 $16.77M $28.00M $39.30M $77.84M $29.64M
Other Non-Current Liabilities -- $0 $0 $248K $66K $100K --
Total Non-Current Liabilities $79.94M $74.65M $95.10M $41.64M $53.73M $92.67M $47.46M
Total Liabilities $163.1M $142.4M $180.8M $113.0M $146.3M $203.3M $82.03M
Total Debt (incl. Leases) $82.25M $87.76M $84.67M $17.34M $17.96M $17.99M $21.19M
Common Stock $8.0K $7.0K $6.0K $6.0K $5.0K $4.0K --
Retained Earnings -$1.07B -$754.6M -$530.8M -$383.8M -$229.0M -$128.8M -$76.46M
Accumulated Other Comp. Income $1.80M -$1.49M -$552K -$4.95M -$660K -$128K $6.0K
Total Stockholders' Equity $1.58B $835.6M $395.0M $490.2M $459.6M $283.9M -$74.41M
Total Equity $1.58B $835.6M $395.0M $490.2M $459.6M $283.9M -$74.41M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $373.4M $124.5M $144.1M $357.0M $112.9M $335.8M $89.97M $120.3M
Short-Term Investments $597.8M $566.5M $506.8M $491.3M $392.7M $329.6M $373.2M $368.5M
Cash & Short-Term Investments $971.2M $691.0M $650.9M $848.3M $505.7M $665.4M $463.1M $488.7M
Accounts Receivable, Net -- $20.00M -- $0 -- $40.00M -- $0
Total Current Assets $998.6M $737.3M $677.4M $871.2M $528.3M $728.3M $501.0M $510.3M
Property, Plant & Equipment, Net $38.24M $39.97M $41.62M $43.17M $45.13M $48.57M $49.17M $50.46M
Long-Term Investments $674.7M $813.9M $894.7M $771.2M $473.1M $297.6M $312.3M $362.2M
Other Non-Current Assets $9.11M $7.38M $7.70M $9.11M $6.83M $4.67M $3.31M $1.95M
Total Non-Current Assets $768.7M $908.2M $991.6M $871.6M $573.7M $402.7M $417.4M $467.8M
Total Assets $1.77B $1.65B $1.67B $1.74B $1.10B $1.13B $918.3M $978.0M
Accounts Payable $11.92M $8.92M $12.84M $4.01M $5.51M $5.78M $10.26M $5.99M
Deferred Revenue (Current) $0 $0 $0 $22.93M $23.28M $40.00M $11.48M $13.58M
Other Current Liabilities $905K $236K $976K $242K $408K $117K $893K $223K
Total Current Liabilities $89.72M $71.33M $62.64M $83.21M $71.58M $87.54M $58.99M $67.77M
Deferred Revenue (Non-Current) $0 $0 $0 $11.44M $13.96M -- -- $0
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $63.02M $64.86M $66.74M $79.94M $84.21M $72.05M $73.09M $74.65M
Total Liabilities $152.7M $136.2M $129.4M $163.1M $155.8M $159.6M $132.1M $142.4M
Total Debt (incl. Leases) $76.60M $78.56M $80.47M $82.25M $84.00M $85.71M $86.33M $87.76M
Common Stock $9.0K $8.0K $8.0K $8.0K $7.0K $7.0K $7.0K $7.0K
Retained Earnings -$1.33B -$1.20B -$1.14B -$1.07B -$979.0M -$896.8M -$820.2M -$754.6M
Accumulated Other Comp. Income -$14.73M -$7.16M -$4.19M $1.80M $1.50M $279K -$58K -$1.49M
Total Stockholders' Equity $1.61B $1.51B $1.54B $1.58B $946.3M $971.5M $786.2M $835.6M
Total Equity $1.61B $1.51B $1.54B $1.58B $946.3M $971.5M $786.2M $835.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$311.4M -$223.9M -$147.0M -$154.8M -$100.2M -$45.59M -$41.25M
Depreciation & Amortization $8.31M $7.37M $3.56M $2.98M $2.40M $1.76M $825K
Stock-Based Compensation $59.90M $55.01M $43.12M $35.48M $24.97M $5.19M $1.20M
Change in Payables -$1.97M -$307K $2.04M $253K $54K $990K $904K
Operating Cash Flow -$232.9M -$194.5M -$102.8M -$153.1M -$128.9M $88.13M $17.91M
Capital Expenditure -$1.45M -$12.84M -$34.48M -$2.84M -$1.60M -$9.10M -$532K
Free Cash Flow -$234.3M -$207.3M -$137.3M -$155.9M -$130.5M $79.03M $17.37M
Purchases of Investments -$1.01B -$901.2M -$189.2M -$446.0M -$456.4M -$529.4M -$15.95M
Investing Cash Flow -$521.1M -$404.1M $139.9M $20.52M -$99.83M -$422.6M -$16.49M
Financing Cash Flow $990.7M $608.9M $4.19M $153.0M $250.3M $289.3M $34.91M
Net Change in Cash $236.8M $10.27M $41.25M $20.43M $21.50M -$45.20M $36.33M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$132.0M -$61.21M -$69.23M -$86.98M -$82.17M -$76.61M -$65.58M -$70.75M
Depreciation & Amortization $2.02M $2.03M $2.02M $2.03M $2.15M $2.08M $2.05M $1.99M
Stock-Based Compensation $18.84M $18.94M $16.01M $14.45M $15.80M $15.42M $14.23M $13.80M
Change in Payables $3.02M -$3.94M $8.82M -$1.49M -$267K -$4.13M $3.92M -$505K
Operating Cash Flow -$77.91M -$54.06M -$88.84M -$66.75M -$27.11M -$59.88M -$79.15M -$61.78M
Capital Expenditure -$315K -$473K -$434K -$106K -$181K -$695K -$467K -$936K
Free Cash Flow -$78.23M -$54.54M -$89.27M -$66.85M -$27.29M -$60.58M -$79.62M -$62.72M
Purchases of Investments -$60.66M -$114.7M -$276.3M -- -$367.6M -$58.25M -$83.66M --
Sales & Maturities of Investments $162.6M $135.2M $133.9M -- $132.4M $119.0M $132.7M --
Investing Cash Flow $101.6M $20.05M -$142.8M -$394.4M -$235.3M $60.02M $48.62M $68.57M
Financing Cash Flow $225.6M $14.42M $18.77M $705.2M $39.51M $245.7M $258K $2.77M
Net Change in Cash $249.3M -$19.60M -$212.9M $244.1M -$222.9M $245.9M -$30.28M $9.55M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 0.0% 0.0% 0.0% 0.0% -- -- --
Operating Margin -891.1% -555.8% -210.6% -344.4% -138.0% -136.1% -1438.5%
Net Profit Margin -794.0% -475.6% -187.0% -330.6% -137.6% -134.0% -1405.8%
Return on Equity (ROE) -19.7% -26.8% -37.2% -31.6% -21.8% -16.1% --
Return on Assets (ROA) -17.9% -22.9% -25.5% -25.7% -16.5% -9.4% -35.3%
Current Ratio 10.47x 7.53x 4.73x 5.88x 4.88x 2.73x 2.69x
Quick Ratio 10.19x 7.21x 4.55x 5.71x 4.78x 2.68x 2.66x
Debt to Equity 0.05x 0.11x 0.21x 0.04x 0.04x 0.06x --
Revenue Growth (YoY) -16.7% -40.1% +67.8% -35.7% +114.0% +1060.0% --
Operating Cash Flow Growth (YoY) -- -- -- -- -246.3% +392.2% --
Free Cash Flow Growth (YoY) -- -- -- -- -265.2% +354.9% --
5Y Revenue / Share Growth -76.3% -63.7% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Operating Margin -396.0% -333.5% -697.7% -891.1% -759.7% -697.5% -472.5% -555.8%
Net Profit Margin -341.8% -285.3% -612.0% -794.1% -674.8% -616.0% -409.1% -475.6%
Return on Equity (ROE) -21.6% -19.9% -20.5% -19.7% -31.2% -28.4% -30.6% -26.8%
Return on Assets (ROA) -19.8% -18.2% -18.9% -17.9% -26.8% -24.4% -26.2% -22.9%
Current Ratio 11.13x 10.34x 10.81x 10.47x 7.38x 8.32x 8.49x 7.53x
Quick Ratio 10.82x 9.97x 10.39x 10.19x 7.07x 8.06x 7.85x 7.21x
Debt to Equity 0.05x 0.05x 0.05x 0.05x 0.09x 0.09x 0.11x 0.11x
Revenue Growth (YoY) -100.0% +466.4% +55.5% -61.2% -26.1% -55.3% +114.8% -84.6%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -868.0%
Source: SEC EDGAR CompanyFacts (CIK 0001815442) · from September 30, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:09 UTC · Open in terminal